Brod SA - Search Results

1

The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica.

Brod SA. Brod SA. Autoimmun Rev. 2022 Oct;21(10):103170. doi: 10.1016/j.autrev.2022.103170. Epub 2022 Aug 11. Autoimmun Rev. 2022. PMID: 35963569 Review.

2

Immune reconstitution therapy in NMOSD.

Brod SA. Brod SA. Mult Scler Relat Disord. 2021 Jul;52:102971. doi: 10.1016/j.msard.2021.102971. Epub 2021 May 4. Mult Scler Relat Disord. 2021. PMID: 33992916 Review.

3

A proposal: How to study pro-myelinating proteins in MS.

Brod SA. Brod SA. Autoimmun Rev. 2022 Jan;21(1):102924. doi: 10.1016/j.autrev.2021.102924. Epub 2021 Aug 17. Autoimmun Rev. 2022. PMID: 34416371 Review.

4

In MS: Immunosuppression is passé.

Brod SA. Brod SA. Mult Scler Relat Disord. 2020 May;40:101967. doi: 10.1016/j.msard.2020.101967. Epub 2020 Jan 24. Mult Scler Relat Disord. 2020. PMID: 32007655 Review.

5

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects.

Brod SA. Brod SA. Mult Scler Relat Disord. 2020 Nov;46:102538. doi: 10.1016/j.msard.2020.102538. Epub 2020 Oct 7. Mult Scler Relat Disord. 2020. PMID: 33059216 Free PMC article. Review.

6

Variable results after rituximab in neuromyelitis optica.

Lindsey JW, Meulmester KM, Brod SA, Nelson F, Wolinsky JS. Lindsey JW, et al. Among authors: brod sa. J Neurol Sci. 2012 Jun 15;317(1-2):103-5. doi: 10.1016/j.jns.2012.02.017. Epub 2012 Mar 9. J Neurol Sci. 2012. PMID: 22405926 Review.

7

Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis.

Brod SA, Scott M. Brod SA, et al. Autoimmunity. 1994;17(2):143-8. doi: 10.3109/08916939409014669. Autoimmunity. 1994. PMID: 7520286

8

Hypothesis: multiple sclerosis is a type I interferon deficiency syndrome.

Brod SA. Brod SA. Proc Soc Exp Biol Med. 1998 Sep;218(4):278-83. doi: 10.3181/00379727-218-44295. Proc Soc Exp Biol Med. 1998. PMID: 9714071 Review. No abstract available.

9

Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Dittel LJ, Dittel BN, Brod SA. Dittel LJ, et al. Among authors: brod sa. Immunohorizons. 2022 Jul 22;6(7):497-506. doi: 10.4049/immunohorizons.2200023. Immunohorizons. 2022. PMID: 35868840 Free PMC article.

10

Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.

Brod SA, Khan M. Brod SA, et al. J Autoimmun. 1996 Feb;9(1):11-20. doi: 10.1006/jaut.1996.0003. J Autoimmun. 1996. PMID: 8845048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page